Seres Therapeutics, Inc. (MCRB) — Net Income

Annual figures by fiscal year, from SEC filings.

2013: -$6.10M2014: -$16.71M2015: -$54.78M2016: -$91.58M2017: -$89.38M2018: -$98.94M2019: -$70.28M2020: -$89.13M2021: -$65.58M2022: -$250.16M2023: -$113.72M2024: $136.0K2025: $5.70M$5.70M
2013Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025$5.70M+4088.2%
2024$136.0K+100.1%
2023-$113.72M+54.5%
2022-$250.16M-281.5%
2021-$65.58M+26.4%
2020-$89.13M-26.8%
2019-$70.28M+29.0%
2018-$98.94M-10.7%
2017-$89.38M+2.4%
2016-$91.58M-67.2%
2015-$54.78M-227.8%
2014-$16.71M-173.8%
2013-$6.10M